Vertex announced U.S. FDA approval for TRIKAFTAᆴ in children with cystic fibrosis ages 2 through 5 with certain mutations
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
On Apr. 25, 2023, the U.S. FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS)…
On Apr. 24, 2023, the U.S. Food and Drug Administration (FDA) authorized Status COVID-19 Antigen Rapid Test for…
On Apr. 24, 2023, Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center in Biberach an der Ri�, Germany….
On Apr. 23, 2023, the most comprehensive state-by-state analysis of the impacts of COVID-19 across the USA, published…
On Apr. 20, 2023, Massachusetts Institute of Technology (MIT) researchers announced that have developed machine-learning algorithms that can…
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
On Apr. 17, 2023, a new initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics…
On Apr. 17, 2023, the U.S. FDA approved Gamida Cell’s Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord…
On Apr. 15, 2023, the World Health Organization (WHO) announced that six additional laboratory-confirmed cases of Marburg virus…
On Apr. 14, 2023, Revance Therapeutics announced that the U.S. Food and Drug Administration (FDA) had approved the…
On Apr. 14, 2023, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for the…
On Apr. 14, 2023, the National Health Commission of the People’s Republic of China reported a confirmed case…
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers announced…
On Apr. 11, 2023, a National Institutes of Health (NIH) clinical trial was stopped early because a daily…
On Apr. 10, 2023, the U.S. Department of Health and Human Services (HHS) announced it was spending over…
On Apr. 10, 2023, the U.S. Food and Drug Administration authorized for marketing Moximed’s MISHA Knee System, an…
On Apr. 7, 2023, the U.S. National Park Service reported Highly Pathogenic Avian Influenza (HPAI) had been confirmed…
On Apr. 5, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
On Apr. 5, 2023, researchers at Oregon Health & Science University’s OHSU Casey Eye Institute announced that gene…
On Apr. 5, 2023, the Food and Agriculture Organization (FAO), in collaboration with the World Health Organization (WHO),…
On Apr. 5, 2023, Aberdeen Proving Ground South, formerly known as Edgewood, celebrated the opening of the Department…
On Apr. 4, 2023, NanoViricides announced that it had executed a license agreement with Karveer Meditech, Kolhapur, India,…
On Apr. 4, 2023, National Institutes of Health (NIH) funded research was announced from the University of Rochester…
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
On Apr. 3, 2023, a study from the National Eye Institute (NEI) identified rare genetic variants that could…
On Mar. 31, 2023, the Oregon Department of Agriculture and the United States Department of Agriculture’s Animal and…
On Mar. 30, 2023, Moderna and the Government of the Republic of Kenya announced they had finalized an…
On Mar. 29, 2023, the mortality gap between the United States and other high-income nations substantially expanded during…
On Mar. 29, 2023, the World Health Organization (WHO) announced that it had certified Azerbaijan and Tajikistan for…